Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Day One Biopharmaceuticals (DAWN) EPS (Basic): 2022-2024

Historic EPS (Basic) for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Dec 2024 value amounting to -$1.02.

  • Day One Biopharmaceuticals' EPS (Basic) fell 150.00% to -$0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.52, marking a year-over-year decrease of 47.57%. This contributed to the annual value of -$1.02 for FY2024, which is 56.96% up from last year.
  • Day One Biopharmaceuticals' EPS (Basic) amounted to -$1.02 in FY2024, which was up 56.96% from -$2.37 recorded in FY2023.
  • Over the past 5 years, Day One Biopharmaceuticals' EPS (Basic) peaked at -$1.02 during FY2024, and registered a low of -$2.37 during FY2023.
  • For the 3-year period, Day One Biopharmaceuticals' EPS (Basic) averaged around -$1.85, with its median value being -$2.17 (2022).
  • In the last 5 years, Day One Biopharmaceuticals' EPS (Basic) fell by 9.22% in 2023 and then soared by 56.96% in 2024.
  • Day One Biopharmaceuticals' EPS (Basic) (Yearly) stood at -$2.17 in 2022, then decreased by 9.22% to -$2.37 in 2023, then skyrocketed by 56.96% to -$1.02 in 2024.